In reply – on the toxicity of ibogaine
Tibor M Brunt, Ruud P. W. Litjens
Clinical Toxicology May 31, 2016 DOI: 10.1080/15563650.2016.1190018 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary or letter Peer reviewed |
|---|---|
| Topics | Ibogaine |
| Key points | The authors concur that ibogaine and iboga-derived substances lack a clear therapeutic dose margin, but the abstract is incomplete, preventing a full summary of their argument. |
Abstract
We concur with the observation of the authors that ibogaine does not seem to have a clear therapeutic dose margin, nor does iboga extracts or the root bark of iboga. However, what they consider to ...
Citations in the library
Cites 4
- Fatalities temporally associated with the ingestion of ibogaine. Journal of Forensic Sciences March 1, 2012
- How toxic is ibogaine? Clinical Toxicology 2016
- hERG Blockade by Iboga Alkaloids. Cardiovascular toxicology 2016
- Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration. European Journal of Pharmacology October 1, 2008